See below for the chat box. Join us every Thursday at 15 pm EST for a live conversation with scientists and experts worldwide.
Today Topic
The curing or prevention of complex diseases is one of the most ambitious health goals Here. Since the late 190s, researchers tried-and mostly failed to accomplish this in type 1 diabetes, an immune disease that destroys the pancreas cells that make insulin, which mainly affects children. This summer, a large number of new studies reported the results of efforts to change the balance of immune system cells in hopes of keeping the disease at bay. The results show how difficult it is to intervene successfully. Why is it so difficult to get from a scientific discovery to a new drug? Is the prevention of diseases difficult or easier than treating patients who have already? What does the road look like?
Join us for a live chat to 3:00 p.m. EDT Thursday, August 11 , this page. You can leave your questions in the comment box below before the discussion begins
Save to my calendar
. <-! Additional reading:
URL 1
URL 2
->
guest today
Jay S. Skyler
Jay S. Skyler, MD, MACP, joined the University of Miami in 1976, where he is currently professor of medicine, pediatrics and psychology. His research interests are in clinical aspects of diabetes, particularly improving the management of type 1 diabetes through meticulous glycemic control, psychosocial and behavioral support, and immune response.
Jeff Bluestone
Jeffrey Bluestone, Ph.D., has been appointed Executive Vice Chancellor and rector of the University of California, San Francisco (UCSF) , March 2010, after serving in a number of positions, including Director, UCSF Diabetes Center and the Network of immune tolerance and Vice Chancellor-looking as interim.
0 Komentar